6533b82ffe1ef96bd1295972

RESEARCH PRODUCT

Anti-type2-Antibodies Specifically Inhibit Murine Asthma Features Induced By Intranasal Application of IL-5 and IL-13

Roland BuhlStephanie KornSebastian ReuterHendrik BeckertHelen Meyer-martin

subject

biologybusiness.industryImmunologymedicine.diseaseImmunologyInterleukin 13biology.proteinImmunology and AllergyMedicineNasal administrationAntibodybusinessInterleukin 5Asthmahttps://doi.org/10.1016/j.jaci.2015.12.239